Cwm LLC Acquires 774 Shares of Cardinal Health, Inc. $CAH

Cwm LLC boosted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 6.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,135 shares of the company’s stock after purchasing an additional 774 shares during the period. Cwm LLC’s holdings in Cardinal Health were worth $2,207,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in CAH. GAMMA Investing LLC grew its position in Cardinal Health by 28.4% in the first quarter. GAMMA Investing LLC now owns 7,004 shares of the company’s stock valued at $965,000 after purchasing an additional 1,549 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Cardinal Health by 15.1% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 35,790 shares of the company’s stock valued at $4,931,000 after purchasing an additional 4,693 shares in the last quarter. Sagespring Wealth Partners LLC bought a new position in Cardinal Health in the first quarter valued at $233,000. Kingswood Wealth Advisors LLC grew its position in shares of Cardinal Health by 17.2% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company’s stock valued at $429,000 after acquiring an additional 457 shares during the period. Finally, Premier Path Wealth Partners LLC bought a new position in shares of Cardinal Health in the 1st quarter valued at about $230,000. Institutional investors own 87.17% of the company’s stock.

Insiders Place Their Bets

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by insiders.

Cardinal Health Stock Performance

Shares of CAH stock opened at $156.29 on Friday. The company has a market capitalization of $37.13 billion, a price-to-earnings ratio of 24.23, a PEG ratio of 1.32 and a beta of 0.71. The company has a 50-day simple moving average of $151.88 and a 200 day simple moving average of $151.81. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a $0.5107 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s payout ratio is 31.63%.

Analyst Ratings Changes

A number of brokerages have recently commented on CAH. Evercore ISI decreased their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 12th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Argus set a $189.00 price objective on shares of Cardinal Health in a research report on Friday, August 22nd. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.